comparemela.com

Latest Breaking News On - Drug regulation authority of pakistan - Page 1 : comparemela.com

Covid-19: Pakistan approves second Chinese vaccine--China Economic Net

  Karachi, February 13: Pakistan on Friday evening confirmed it had approved the second Chinese vaccine against the Covid-19 pandemic.   Special Assistant to the Prime Minister on health Dr Faisal Sultan said the government had given authorization of the emergency use of single-dose CanSino vaccine.   The approval by Drug Regulation Authority of Pakistan (DRAP), he said, had been given after a “successful” phase-three trials of the vaccine in the country.   Pakistan is the second country after Mexico to have authorized the emergency use of the CanSino vaccine. Islamabad has already authorized the emergency use of China’s Sinopharm, Oxford-AstraZeneca, and Russia’s Sputnik vaccine.

Pakistan
China
Mexico
Karachi
Sindh
Islamabad
Chinese
Pakistani
Liao-yifan
Faisal-sultan
Shafqat-ali
Drug-regulation-authority-of-pakistan

Pakistani origin Russian scientist invents medicine for COVID-19

Islamabad January 24, 2021 Islamabad:Pakistani origin Russian scientist Prof. Dr. Jan Alam Saturday introduced the media to a mineral-based medicine invented by him for the treatment of coronavirus. Based on nanotechnology, Minerolytevir is a 5th generation medicine that has been registered by the Drug Regulation Authority of Pakistan (DRAP). Addressing a press conference at the National Press Club, Dr. Jan claimed that the medicine has no side-effects, is completely safe for human beings, and can even be used by a day-old child. “A patient diagnosed with COVID-19 can be cured within 10 days by using this medicine. Patients on ventilatory support can be saved by using it through nebulisation. Just one mist of spray on the face and other body parts saves a person for 3-4 hours in these crucial days of the pandemic,” Dr. Jan claimed.

Geneva
Gene
Switzerland
Paris
France-general
France
Russia
Pakistan
Islamabad
Russian
Pakistani
Jan-alam

vimarsana © 2020. All Rights Reserved.